Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Bruker Corporation

Stage 2 · Advancing · week 21

As of Oct 22, 2026, Bruker is in Stage 2, the uptrend phase, now in week 21 (since Jun 1, 2026). It closed at $57.31, 11.5% below its 52-week high and above its 200-day average, which is rising.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. More about the company

$57.31
-3.04% today
$8.7B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is BRKR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 16w
S2 15w
S4 14w
S4 20w
S2 21w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S3 1w → S4 16w → S1 6w → S2 15w → S3 6w → S4 12w → S1 5w → S4 14w → S1 2w → S4 20w → S1 6w → S4 11w → S1 5w → S2 11w → S3 6w → S4 7w → S1 2w → S2 21w current
Total tracked: 165 weeks across 18 stage runs.

BRKR among Medical Devices15th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…15BRKRStage 2 · wk 2185−4.0%
vs 52W High
-11.5%
$32.66 lo$64.75 hi
11.5% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 21
1w13w26w
Week 21, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
14.8%
200 DMA: $49.92 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.10x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-4.0%
3M
-5.1%
6M
+58.5%
YTD
+19.5%
1Y
+48.4%
Scan Membership
Breakout Watch
Latest: 2024-01-25
7 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 21 · Vol 1.10x
2026-10-21S2
Wk 20 · Vol 1.47x
2026-10-20S2
Wk 20 · Vol 0.73x
2026-10-19S2
Wk 20 · Vol 0.89x
2026-10-16S2
Wk 20 · Vol 0.78x
2026-10-15S2
Wk 20 · Vol 0.96x
2026-10-14S2
Wk 19 · Vol 1.00x
2026-10-13S2
Wk 19 · Vol 0.93x
2026-10-12S2
Wk 19 · Vol 0.80x
2026-10-09S2
Wk 19 · Vol 0.62x
2026-10-08S2
Wk 19 · Vol 1.09x
2026-10-07S2
Wk 18 · Vol 1.24x
Moving averages & range
50 DMA
$58.70
200 DMA
$49.92
52W High
$64.75
52W Low
$32.66
5D Low
$54.80
Resistance levels (recent highs)
20d High
$64.75
60d High
$64.75
120d High
$64.75
250d High
$64.75
Next resistance
+13.0%
to 20d High
ROE
-3.0%
Profit margin -2.0%
Dividend Yield
0.34%
P/B 3.7

Bruker: quick answers

What stage is Bruker in?

As of Oct 22, 2026, Bruker (BRKR) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 1, 2026 and is in week 21. What the four stages mean

Is Bruker in an uptrend?

Yes. Bruker is in a Stage 2 uptrend. It trades 14.8% above its 200-day average, which is rising.

How far is Bruker from its 52-week high?

Bruker closed at $57.31 on Oct 22, 2026, 11.5% below its 52-week high of $64.75. Its 52-week low is $32.66.

How has Bruker performed over the past year?

As of Oct 22, 2026, Bruker is up 48.4% over the past year and up 19.5% so far in 2026.

Which sector and industry is Bruker in?

Bruker is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.